Holen Sie sich die Stockscreener-App
8.925
3.20%
0.175
Schlusskurs vom Vortag:
$8.75
Offen:
$8.65
24-Stunden-Volumen:
116.98K
Relative Volume:
0.85
Marktkapitalisierung:
$453.18M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-25.50M
KGV:
-11.59
EPS:
-0.77
Netto-Cashflow:
$-30.10M
1W Leistung:
+8.66%
1M Leistung:
+37.65%
6M Leistung:
+70.77%
1J Leistung:
+182.19%
1-Tages-Spanne:
$8.60
$9.08
1-Wochen-Bereich:
$8.07
$9.08
52-Wochen-Spanne:
$2.6801
$9.08
Eupraxia Pharmaceuticals Inc Stock (EPRX) Company Profile
Firmenname
Eupraxia Pharmaceuticals Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie EPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EPRX
Eupraxia Pharmaceuticals Inc
|
8.9476 | 443.17M | 0 | -25.50M | -30.10M | -0.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.63 | 111.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
734.21 | 77.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
808.61 | 49.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.88 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
334.17 | 37.42B | 4.98B | 69.59M | 525.67M | 0.5197 |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-06-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-06-16 | Eingeleitet | Canaccord Genuity | Speculative Buy |
| 2025-02-21 | Eingeleitet | Craig Hallum | Buy |
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
Eupraxia Pharmaceuticals Inc Aktie (EPRX) Neueste Nachrichten
Aug Retail: What are Eupraxia Pharmaceuticals Incs recent SEC filings showingWeekly Trade Report & Real-Time Volume Trigger Notifications - baoquankhu1.vn
(EPRX) Optimized Trading Opportunities (EPRX:CA) - Stock Traders Daily
Aug Catalysts: Will Eupraxia Pharmaceuticals Inc benefit from rising consumer demand2025 Market Overview & Smart Swing Trading Alerts - baoquankhu1.vn
(EPRX) Trading Advice (EPRX:CA) - Stock Traders Daily
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Price Target Raised to $19.00 at Cantor Fitzgerald - Defense World
Cantor Fitzgerald Raises Eupraxia Pharmaceuticals (NASDAQ:EPRX) Price Target to $19.00 - MarketBeat
Cantor Fitzgerald raises Eupraxia Pharmaceuticals stock price target to $19 By Investing.com - Investing.com UK
Buyback Watch: Will Lumentum Holdings Inc be affected by tariffsJuly 2025 Technicals & Free Community Supported Trade Ideas - baoquankhu1.vn
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Receives Average Rating of "Buy" from Analysts - MarketBeat
Cantor Fitzgerald Raises Price Target for EPRX to $19.00, Mainta - GuruFocus
Eupraxia Pharmaceuticals (TSX:EPRX) Price Target Increased by 21.11% to 14.96 - Nasdaq
Short Interest in Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Grows By 138.8% - MarketBeat
Eupraxia Pharmaceuticals (EPRX) Price Target Increased by 21.61% to 10.82 - Nasdaq
(EPRX.WT.A) Investment Performance Report - Stock Traders Daily
Trend Report: What is Eupraxia Pharmaceuticals Incs valuation compared to sectorMarket Trend Review & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Trading Action: Will Eupraxia Pharmaceuticals Inc benefit from rising consumer demandMarket Trend Summary & High Conviction Buy Zone Picks - baoquankhu1.vn
Macro Review: Can Eupraxia Pharmaceuticals Inc grow without dilution2025 Institutional Moves & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Trend Tracker for (EPRX) (EPRX:CA) - Stock Traders Daily
(EPRX) Trading Strategy and Analysis (EPRX:CA) - Stock Traders Daily
Can Eupraxia Pharmaceuticals Inc. stock sustain institutional interest2025 Key Highlights & Expert Verified Movement Alerts - Улправда
Eupraxia Pharmaceuticals’ (EPRX) Buy Rating Reaffirmed at HC Wainwright - Defense World
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Given Buy Rating at HC Wainwright - MarketBeat
Eupraxia Pharmaceuticals Inc. (TSE:EPRX) surges 15%; retail investors who own 41% shares profited along with institutions - simplywall.st
Eupraxia Trial Data Shows Lasting Tissue Healing In Patients With Inflamed Esophagus - Sahm
Why Eupraxia Pharmaceuticals Inc. stock could benefit from AI revolution2025 Earnings Impact & AI Forecasted Entry/Exit Points - Улправда
What insider trading reveals about Eupraxia Pharmaceuticals Inc. stockWeekly Investment Summary & Smart Allocation Stock Tips - Улправда
Is Eupraxia Pharmaceuticals Inc. stock a buy on dips2025 Price Action Summary & Stepwise Trade Signal Guides - Улправда
Will Eupraxia Pharmaceuticals Inc. stock continue dividend increases2025 Big Picture & Consistent Growth Stock Picks - Улправда
How Eupraxia Pharmaceuticals Inc. stock reacts to inflationary pressuresJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - Улправда
(EPRX.WT.A) Investment Analysis and Advice - Stock Traders Daily
Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improvement on Biopsy - Investing News Network
Eupraxia Pharmaceuticals Announces Positive Tissue Health Data From Its Ongoing RESOLVE Trial - Nasdaq
Eupraxia Posts Strong Mid-Stage Data for Once-Yearly EoE Therapy EP-104GI - TipRanks
Eupraxia Pharmaceuticals reports positive tissue health data from its ongoing resolve trial - marketscreener.com
Eupraxia Pharmaceuticals Brief: Reporting "Positive" Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improvement on Biopsy - marketscreener.com
(EPRX) Daily Stock Insights (EPRX:CA) - Stock Traders Daily
Eupraxia Pharmaceuticals (OTCMKTS:EPRXF) Trading Up 0.3% – Here’s What Happened - Defense World
(EPRX.WT.A) Advanced Equity Analysis - Stock Traders Daily
(EPRX) Technical Data (EPRX:CA) - Stock Traders Daily
(EPRX.WT.A) Stock Trading Blueprint - Stock Traders Daily
(EPRX) Comprehensive Trading Strategy Report (EPRX:CA) - Stock Traders Daily
(EPRX.WT.A) Daily Stock Insights - Stock Traders Daily
Uncover the Best-Performing Canadian Biotech Stocks of 2025 - Investing News Network
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Short Interest Up 30.1% in December - MarketBeat
Trading (EPRX) With Integrated Risk Controls (EPRX:CA) - Stock Traders Daily
How the (EPRX.WT.A) price action is used to our Advantage - Stock Traders Daily
(EPRX) Equity Market Report (EPRX:CA) - Stock Traders Daily
562,500 Non-Voting Class B Shares of Eupraxia Pharmaceuticals Inc. are subject to a Lock-Up Agreement Ending on 22-DEC-2025. - MarketScreener
Will Eupraxia Pharmaceuticals Inc. stock reach Wall Street targetsEntry Point & Community Verified Swing Trade Signals - Улправда
(EPRX) Advanced Trading Insights (EPRX:CA) - Stock Traders Daily
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Given Consensus Rating of “Buy” by Brokerages - Defense World
Finanzdaten der Eupraxia Pharmaceuticals Inc-Aktie (EPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.64%
1.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):